ID   CiRA-PD82
AC   CVCL_DR16
SY   Cira82
DR   GEO; GSM1489202
DR   GEO; GSM1489437
DR   GEO; GSM1942575
DR   Wikidata; Q54813381
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M.,
RA   Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M.,
RA   Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A.,
RA   Yamanaka S., Yoshida Y.;
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//